glp-1 drug class Agonists Explained: Definition, How They Work, Side Effects GLP-1s for Weight Loss: What

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist

This newly charted pathway - separate from previously described mechanisms that broadly affect appetite - could be an avenue by which GLP-1s treat other dysfunctions in reward processing, such as substance use disorder

Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner

This has raised concerns about their impact on cancer risk, spurring extensive research

Find safe, over-the-counter supplements to support your GLP-1 journey

Source in comments.